Department of Cardiology, University of Texas Health Science Center at Houston, Houston, TX, USA.
Department of Medicine, Cheshire Medical and Dartmouth-Hitchcock Keene, Keene, NH, USA.
J Cardiovasc Electrophysiol. 2018 Sep;29(9):1268-1275. doi: 10.1111/jce.13659. Epub 2018 Jun 22.
An increasing number of patients with cardiac devices require radiation therapy for treatment of a variety of cancers. This study aimed to identify the incidence and predictors of cardiac implantable electronic devices (CIED) malfunction in a real-world population that has received radiation therapy.
This retrospective cohort study included 109 adult patients who received radiation therapy at the University of Rochester Medical Center, Radiation Oncology Department, between 2000 and 2015. Sixty patients had pacemakers and 49 had automatic implantable cardioverter defibrillators. Subjects received either high energy (16 MV) and/or low energy (6 MV) photon beams with or without electron beams (6-16 MeV). We included interrogations done from first day of radiation and up to 3 months' postradiation therapy. Outcomes analyzed were device-related malfunctions and device-related clinical events. Fisher's exact, Wilcoxon, and Kruskall-Wallis tests were used for bivariate analysis. Logistic regression with robust adjustment was used for multivariate analysis.
We identified six device-related malfunctions. All events were minor and included partial settings reset leading to loss of historical data, pacing thresholds changes, lead impedance changes, and LV output increase. Two patients had device-related clinical events, including dyspnea and diaphragmatic-stimulation. In bivariate analysis, CIED malfunction was associated with CIED duration in situ. In multivariate analysis, there was no significant statistical association between adverse events and beam energy type, CIED location, or dose of radiation delivered to the target.
CIED malfunctions are uncommon in real-world patients and associated with minor clinical events. In our cohort, remote CIED monitoring would have identified all events.
越来越多的心脏设备患者需要接受放射治疗来治疗各种癌症。本研究旨在确定在接受放射治疗的真实人群中,心脏植入式电子设备(CIED)发生故障的发生率和预测因素。
本回顾性队列研究纳入了 2000 年至 2015 年间在罗切斯特大学医学中心放射肿瘤科接受放射治疗的 109 例成年患者。其中 60 例患者装有起搏器,49 例患者装有自动植入式心脏除颤器。受试者接受高能(16MV)和/或低能(6MV)光子束治疗,同时或不使用电子束(6-16MeV)。我们包括了从放射治疗第一天到治疗后 3 个月的设备检测。分析的结果是设备相关的故障和设备相关的临床事件。使用 Fisher 确切检验、Wilcoxon 检验和 Kruskal-Wallis 检验进行双变量分析。使用稳健调整的逻辑回归进行多变量分析。
我们发现了 6 例设备相关故障。所有事件均为轻微,包括部分设置重置导致历史数据丢失、起搏阈值变化、导联阻抗变化和 LV 输出增加。有 2 例患者发生了设备相关的临床事件,包括呼吸困难和膈肌刺激。在双变量分析中,CIED 故障与 CIED 原位持续时间有关。在多变量分析中,不良事件与射束能量类型、CIED 位置或靶区接受的辐射剂量之间没有显著的统计学关联。
在真实世界的患者中,CIED 故障并不常见,且与轻微的临床事件相关。在我们的队列中,远程 CIED 监测可以发现所有的事件。